TYSND1

TYSND1 is a peroxisomal matrix endopeptidase that processes the enzymes of the fatty acid beta-oxidation pathway and thereby governs their correct localization and activity (PMID:17255948, PMID:23459139). Targeted to the peroxisomal matrix by a PTS1 signal, it performs two distinct proteolytic functions: it removes the N-terminal PTS2 leader peptide from PTS2-containing precursors (Acaa1/prethiolase, and the substrates Phyh and Agps) and carries out specific limited cleavage of PTS1-containing beta-oxidation enzymes (Acox1, Hsd17b4, ScpX) (PMID:17255948, PMID:23459139). This processing is required for the proper peroxisomal localization of substrates such as Acaa1, Phyh, and Agps, and its activity sustains beta-oxidation of very long-chain fatty acids (PMID:22002062, PMID:23459139). Genetic loss of Tysnd1 in mice produces unprocessed substrate accumulation, altered plasmalogen composition, male infertility from acrosomal cap defects, and phytol-induced liver dysfunction resembling the mild Zellweger syndrome spectrum (PMID:23459139). TYSND1 is itself regulated by intermolecular autocatalytic self-cleavage that converts the active 60-kDa form into inactive 15- and 45-kDa chains, which are then degraded by the peroxisomal Lon protease LONP2/PsLon, establishing a proteolytic regulatory cascade for peroxisomal protein quality control (PMID:22002062, PMID:37736739). Its expression is induced by the PPARalpha agonist bezafibrate (PMID:17255948).

1. 2007 High

   Established TYSND1 as a peroxisomal protease performing the dual reactions needed to mature beta-oxidation enzymes, answering how PTS2 leaders are removed and PTS1 enzymes are limited-cleaved within the peroxisome.

   Evidence Biochemical characterization with in vitro protease assays and substrate identification, plus bezafibrate induction assay

   PMID:17255948

   Open questions at the time

   • Catalytic class (cysteine vs serine) not definitively resolved at this stage
   • In vivo physiological relevance not yet tested
   • Functional consequence of autocatalytic processing not quantified
2. 2007 Medium

   Proposed that TYSND1-mediated processing promotes assembly of beta-oxidation enzymes into a supramolecular complex to accelerate the pathway, framing processing as functional rather than merely targeting-related.

   Evidence Model proposed from substrate identification and processing assays

   PMID:17255948

   Open questions at the time

   • Supramolecular complex assembly not directly reconstituted
   • No structural evidence for the proposed complex
   • Kinetic enhancement of beta-oxidation by complex assembly not demonstrated
3. 2011 High

   Demonstrated that TYSND1, not PsLon, is the key processing protease for endogenous substrates and defined a self-cleavage/degradation circuit controlling its activity.

   Evidence Reciprocal siRNA knockdown of Tysnd1 and PsLon with Western blot for substrate processing and a fatty acid beta-oxidation assay

   PMID:22002062

   Open questions at the time

   • Trigger and regulation of intermolecular self-cleavage not defined
   • Knockdown does not exclude indirect effects on beta-oxidation
   • PTS1 matrix localization shown by fractionation but recruitment mechanism not detailed
4. 2013 High

   Validated TYSND1 substrate processing and localization dependency in vivo and linked its loss to defined lipid-metabolic and developmental pathologies, and identified the cysteine endopeptidase activity plus novel substrates Phyh and Agps.

   Evidence Tysnd1 knockout mouse with substrate-processing Western blots, peroxisomal localization assays, lipidomics, and histology

   PMID:23459139

   Open questions at the time

   • Direct human disease association not established
   • Mechanism linking processing defects to acrosomal cap defects not resolved
   • Whether all substrates require processing for activity versus localization not separated
5. 2018 Medium

   Mapped TYSND1 into a broader peroxisomal protein interaction network regulating beta-oxidation, beginning to place the protease in its physical interactome.

   Evidence Co-immunoprecipitation combined with mass spectrometry in mammalian cells

   PMID:30378028

   Open questions at the time

   • Single IP-MS without reciprocal validation
   • No functional follow-up of identified interactors
   • Direct versus indirect partners not distinguished
6. 2023 Medium

   Confirmed LONP2/PsLon as the degrader of TYSND1, closing the proteolytic cascade, while showing TYSND1-dependent ACOX1 processing is buffered against early proteotoxic stress.

   Evidence siRNA knockdown of LONP2 with Western blot for TYSND1 and ACOX1 processing and peroxisomal phenotype analysis

   PMID:37736739

   Open questions at the time

   • Direct degradation of TYSND1 cleavage products by LONP2 not reconstituted
   • Stress conditions under which the cascade becomes rate-limiting not defined
   • Physiological role of TYSND1 accumulation unclear

• How TYSND1 self-cleavage is triggered and integrated with substrate flux to set peroxisomal beta-oxidation rates, and whether TYSND1 variants cause human peroxisomal disease, remains unresolved.
• Regulatory trigger of autocatalytic self-cleavage unknown
• No structural model of the active enzyme or substrate recognition
• No reported human Mendelian disease link